Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Cladribine, Interferon alfa-2a/2b, Clonal haematopoiesis (CHIP), Driver mutation and the tags rare, haematologic.
Shares Langerhans cell histiocytosis (LCH) and the tags rare, haematologic.
Shares Rare and paediatric cancers without markets, Cyclophosphamide, Doxorubicin and the tags rare, haematologic.
Shares Cladribine, Interferon alfa-2a/2b, Vemurafenib, Dabrafenib + trametinib and the tag haematologic.
Shares Etoposide, Cyclophosphamide, Doxorubicin and the tags rare, haematologic.
Shares Interferon alfa-2a/2b, Cyclophosphamide and the tags rare, haematologic.
Shares Histiocyte Society, Langerhans cell histiocytosis (LCH), BRAF, RAS / RAF / MEK / ERK (MAPK) and the tag histiocytosis.
Shares Cladribine, Rosai-Dorfman-Destombes disease, BRAF V600E mutation, Langerhans cell histiocytosis (LCH).
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.